Web-Based System Works Well for Diagnosis, Treatment of Recurrent Vertigo
Recurrent benign paroxysmal positional vertigo resolved for 72.4 percent of patients using web-based system
Recurrent benign paroxysmal positional vertigo resolved for 72.4 percent of patients using web-based system
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
In predominantly middle-aged cohort, higher omega-3 index linked to larger hippocampal volumes, better abstract reasoning
Amoeba can cause primary amebic meningoencephalitis, a brain infection that is extremely rare, but nearly always fatal
Memory impairment and decreased concentration most prevalent symptoms at six-month follow-up
Amvuttra is a subcutaneously-administered RNAi therapeutic designed to block the production of wild-type and mutant transthyretin protein.
Reduction in frequency of drop seizures greater with fenfluramine versus placebo
Decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking
BCX9930 is an investigational oral Factor D inhibitor.
Deficits increased with severity of ongoing self-reported symptoms; severity of initial illness did not influence later cognitive performance